Blood Cancer Journal (Nov 2022)
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
- Sameer A. Parikh,
- Sara J. Achenbach,
- Kari G. Rabe,
- Aaron D. Norman,
- Nicholas J. Boddicker,
- Janet E. Olson,
- Timothy G. Call,
- James R. Cerhan,
- Celine M. Vachon,
- Neil E. Kay,
- Esteban Braggio,
- Curtis A. Hanson,
- Susan L. Slager,
- Tait D. Shanafelt
Affiliations
- Sameer A. Parikh
- Division of Hematology, Mayo Clinic
- Sara J. Achenbach
- Division of Computational Biology, Mayo Clinic
- Kari G. Rabe
- Division of Computational Biology, Mayo Clinic
- Aaron D. Norman
- Division of Clinical Trials and Biostatistics, Mayo Clinic
- Nicholas J. Boddicker
- Division of Computational Biology, Mayo Clinic
- Janet E. Olson
- Division of Epidemiology, Mayo Clinic
- Timothy G. Call
- Division of Hematology, Mayo Clinic
- James R. Cerhan
- Division of Epidemiology, Mayo Clinic
- Celine M. Vachon
- Division of Epidemiology, Mayo Clinic
- Neil E. Kay
- Division of Hematology, Mayo Clinic
- Esteban Braggio
- Department of Hematology and Oncology, Mayo Clinic
- Curtis A. Hanson
- Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic
- Susan L. Slager
- Division of Hematology, Mayo Clinic
- Tait D. Shanafelt
- Department of Medicine, Division of Hematology, Stanford University
- DOI
- https://doi.org/10.1038/s41408-022-00754-x
- Journal volume & issue
-
Vol. 12,
no. 11
pp. 1 – 3
Abstract
No abstracts available.